| Next 10 |
Ad
NCNA News and Press NuCana plc
News | NuCana plc (NASDAQ:NCNA)
-
EDINBURGH, United Kingdom, Sept. 18, 2023 (GLOBE NEWSWIRE) -- NuCana plc (NASDAQ: NCNA) announced four presentations at the upcoming AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 2023 being held October 11-15, 2023 in Boston, Massachusetts. The details o...
-
2023-08-17 06:53:06 ET Summary NuCana is working toward improved chemotherapies for cancer. Early trials to date show some glimmers of promise, but high-profile failures and deficient study design cast a pall on the entire platform. Cash issues present near-term challenges for...
-
2023-08-16 16:31:21 ET More on NuCana NuCana falls 36% after setback for patent dispute in EU for Gilead’s antiviral NuCana gets Nasdaq non-compliance notice on minimum bid price NuCana falls on decision to halt late-stage study for biliary tract cancer ...
-
On Track to Present Data Updates from All Ongoing Clinical Studies in the Second Half of 2023 Well Capitaliz ed with Anticipated Cash Runway into 2025 EDINBURGH, United Kingdom, Aug. 16, ...
-
EDINBURGH, United Kingdom, June 01, 2023 (GLOBE NEWSWIRE) -- NuCana plc (NASDAQ: NCNA) announced today that Hugh Griffith, Chief Executive Officer, and Don Munoz, Chief Financial Officer, will present and host one-on-one meetings at the Jefferies Healthcare Conference. Event: Jefferies Heal...
-
2023-05-17 16:36:08 ET NuCana press release ( NASDAQ: NCNA ): Q1 GAAP EPS of -£0.15. As of March 31, 2023, NuCana had cash and cash equivalents of £31.0 million compared to £41.9 million at December 31, 2022. For further details see: NuCana GAAP EP...
-
Multiple Important Data Readouts Remain on Track for 2023 Well Capitalized with Anticipated Cash Runway into 2025 EDINBURGH, United Kingdom, May 17, 2023 (GLOBE NEWSWIRE) -- NuCana plc (NASDAQ: NCNA) announced financial results for the first quarter ended March 31, 2023 and ...
-
2023-05-12 16:24:48 ET NuCana ( NASDAQ: NCNA ) said Friday that it received a letter from the Nasdaq dated May 9, 2023, indicating that the company no longer satisfies a certain listing rule. The Nasdaq letter has no immediate effect on the listing of the ADSs of the company. ...
-
EDINBURGH, United Kingdom, May 12, 2023 (GLOBE NEWSWIRE) -- NuCana plc (NASDAQ: NCNA) announced that it received written notification (the “Notification Letter”) from The Nasdaq Stock Market LLC ("Nasdaq") dated May 9, 2023, indicating that, based upon a closing bid price of less th...
-
NUC-7738 Reduces Secreted Forms of PD-L1 Indicating Potential Synergy with Checkpoint Inhibitors NUC-7738 Decreases Glutaminase in vitro and in Cancer Tissue Demonstrating Potential for Anti-Cancer Activity in Highly Metabolic Tumors ORLANDO, Fla., April 14, 2023 (GLOBE NEWSWIRE) ...
Stock Information
Ad
-
EDINBURGH, United Kingdom, Sept. 18, 2023 (GLOBE NEWSWIRE) -- NuCana plc (NASDAQ:NCNA) announced four presentations at the upcoming AACR-NCI-EOR...
-
EDINBURGH, United Kingdom, Sept. 18, 2023 (GLOBE NEWSWIRE) -- NuCana plc (NASDAQ: NCNA) announced four presentations at the upcoming AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 2023 being held October 11-15, 2023 in Boston, Massachusetts. The details o...
-
Gainers AgriFORCE Growing Systems Ltd. (NASDAQ: AGRI) shares rose 38.7% to $0.1421 in pre-market trading after gaining 10% on Thursday. MSP Recove...